首页> 外文期刊>Clinical ophthalmology >Intensity of side effects of topical glaucoma medication and its influence on adherence behavior in patients with glaucoma
【24h】

Intensity of side effects of topical glaucoma medication and its influence on adherence behavior in patients with glaucoma

机译:青光眼局部用药的副作用强度及其对依从性的影响

获取原文
           

摘要

Background: The aim of this study was to investigate the intensity of side effects that patients attribute to their topical glaucoma medication and their relationship to adherence behavior. Methods: This was a questionnaire-based study of 123?glaucoma patients at a university eye clinic in Erlangen, Germany. An initial questionnaire asked about patient demographic data, the treatment plan, and intensity of side effects, and included Adherence to Refills and Medication Scale 2?(ARMS2) and visual analog scale (VAS-AD) scores. In a follow-up questionnaire, the treatment plan, intensity of side effects, ARMS2, and VAS-AD were reanalyzed. Results: Most patients reported having few side effects, although only 20% said that they had no symptoms suggestive of side effects at all. The patients showed good adherence behavior on both the ARMS2?and VAS-AD scores, which were stable over time. The intensity of side effects experienced in the previous 7?days did not correlate with adherence scores and had no predictive value for adherence. Conclusion: This study could not detect any significant influence of the subjectively experienced intensity of side effects on patients’ adherence behavior. However, we believe that a simple and clear treatment plan with few side effects is still preferred by most patients.
机译:背景:这项研究的目的是调查患者归因于他们的局部青光眼药物的副作用的强度及其与依从行为的关系。方法:这是在德国埃尔兰根的一家大学眼科诊所中对123名青光眼患者进行的基于问卷调查的研究。最初的问卷调查询问了患者的人口统计学数据,治疗计划和副作用的强度,其中包括对补充药的依从性和药物量表2?(ARMS2)和视觉模拟量表(VAS-AD)得分。在后续调查表中,重新分析了治疗计划,副作用强度,ARMS2和VAS-AD。结果:大多数患者报告几乎没有副作用,尽管只有20%的患者说他们根本没有暗示副作用的症状。患者在ARMS2?和VAS-AD评分上均表现出良好的依从性,且随时间稳定。在过去7天中所经历的副作用强度与依从性得分无关,并且对依从性没有预测价值。结论:该研究无法发现主观体验到的副作用强度对患者依从性的任何显着影响。但是,我们认为大多数患者仍然首选简单,明确,副作用少的治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号